Drug Type Small molecule drug |
Synonyms BD 40, BD-40, NSC 303565 + [7] |
Target |
Action inhibitors |
Mechanism DNA inhibitors(DNA inhibitors), Top II inhibitors(Topoisomerase II inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC22H27N5 |
InChIKeyLPHSYQSMAGVYNT-UHFFFAOYSA-N |
CAS Registry65222-35-7 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Phase 2 | France | - | |
| Neoplasms | Phase 2 | - | - | |
| Neoplasms | Phase 2 | - | - |





